These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38964822)

  • 41. Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Wang W; Wen L; Song Z; Shi W; Wang K; Huang W
    Clin Cardiol; 2019 Aug; 42(8):741-752. PubMed ID: 31188483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic thromboembolic pulmonary hypertension: a review of risk factors, management and current challenges.
    Cannon JE; Jenkins DP; Hoole SP
    Expert Rev Cardiovasc Ther; 2022 Jan; 20(1):35-43. PubMed ID: 35081846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.
    Jaïs X; Brenot P; Bouvaist H; Jevnikar M; Canuet M; Chabanne C; Chaouat A; Cottin V; De Groote P; Favrolt N; Horeau-Langlard D; Magro P; Savale L; Prévot G; Renard S; Sitbon O; Parent F; Trésorier R; Tromeur C; Piedvache C; Grimaldi L; Fadel E; Montani D; Humbert M; Simonneau G
    Lancet Respir Med; 2022 Oct; 10(10):961-971. PubMed ID: 35926542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics].
    Valieva ZS; Martynyuk TV
    Ter Arkh; 2022 Aug; 94(7):791-796. PubMed ID: 36286933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension.
    D'Armini AM
    Eur Respir Rev; 2015 Jun; 24(136):253-62. PubMed ID: 26028637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in treatment of chronic thromboembolic pulmonary hypertension.
    Tzoumas A; Peppas S; Sagris M; Papanastasiou CA; Barakakis PA; Bakoyiannis C; Taleb A; Kokkinidis DG; Giannakoulas G
    Thromb Res; 2022 Apr; 212():30-37. PubMed ID: 35217332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic thromboembolic pulmonary hypertension--a diagnostic and therapeutic update.
    Stricker H
    Vasa; 2016; 45(3):195-9. PubMed ID: 27128884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic Thromboembolic Pulmonary Hypertension.
    Teerapuncharoen K; Bag R
    Lung; 2022 Jun; 200(3):283-299. PubMed ID: 35643802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: New Horizons in the Interventional Management of Pulmonary Embolism.
    Rivers-Bowerman MD; Zener R; Jaberi A; de Perrot M; Granton J; Moriarty JM; Tan KT
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):206-215. PubMed ID: 29029716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update in the management of chronic thrombo-embolic pulmonary hypertension.
    Ribas Sola J; Sánchez-Corral Mena MÁ; Riera-Mestre A
    Med Clin (Barc); 2024 Feb; 162(3):126-133. PubMed ID: 37925273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inoperable chronic thromboembolic pulmonary hypertension treated with riociguat: A case study.
    Ortiz-Bautista C; Ochoa-Parra N; Navas-Tejedor P; Morán-Fernández L; Gómez-Sánchez MÁ
    Rev Port Cardiol; 2015 Dec; 34(12):777.e1-5. PubMed ID: 26632111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL; Langleben D; Hemnes AR; Vonk Noordegraaf A; Rosenkranz S; Thenappan T; Hassoun PM; Preston IR; Ghio S; Badagliacca R; Vizza CD; Lang IM; Meier C; Grünig E
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36198418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics.
    Darocha S; Banaszkiewicz M; Pietrasik A; Piłka M; Florczyk M; Wieteska M; Dobosiewicz A; Szmit S; Torbicki A; Kurzyna M
    Int J Cardiol; 2018 Oct; 269():283-288. PubMed ID: 30017517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving spectrum of treatment for CTEPH.
    Khangoora VS; Shlobin OA
    Curr Opin Pulm Med; 2020 Sep; 26(5):406-413. PubMed ID: 32657835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chronic thromboembolic pulmonary hypertension--a position paper].
    Wilkens H; Lang I; Blankenburg T; Grohé C; Guth S; Held M; Klepetko W; Konstantinides S; Kramm T; Krüger U; Lankeit M; Schäfers HJ; Seyfarth HJ; Mayer E
    Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S155-65. PubMed ID: 25084310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM;
    Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018.
    Wilkens H; Konstantinides S; Lang IM; Bunck AC; Gerges M; Gerhardt F; Grgic A; Grohé C; Guth S; Held M; Hinrichs JB; Hoeper MM; Klepetko W; Kramm T; Krüger U; Lankeit M; Meyer BC; Olsson KM; Schäfers HJ; Schmidt M; Seyfarth HJ; Ulrich S; Wiedenroth CB; Mayer E
    Int J Cardiol; 2018 Dec; 272S():69-78. PubMed ID: 30195840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
    McLaughlin VV; Jansa P; Nielsen-Kudsk JE; Halank M; Simonneau G; Grünig E; Ulrich S; Rosenkranz S; Gómez Sánchez MA; Pulido T; Pepke-Zaba J; Barberá JA; Hoeper MM; Vachiéry JL; Lang I; Carvalho F; Meier C; Mueller K; Nikkho S; D'Armini AM
    BMC Pulm Med; 2017 Dec; 17(1):216. PubMed ID: 29282032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension.
    Kenny M; Clarke MM; Pogue KT
    J Pharm Pract; 2022 Jun; 35(3):437-444. PubMed ID: 33084500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.